Page 4,717«..1020..4,7164,7174,7184,719..4,7304,740..»

The day in deals

Posted: Published on January 3rd, 2014

To get deals in your inbox each morning, sign up for ourTerm Sheet newsletter Nest Labs, a Palo Alto, Calif.-based maker of smart home devices like thermostats and smoke detectors, is raising upwards of $150 million in a new VC round that would value the company north of $2 billion, according to Re/code.DSTis expected to lead the round, with return backers including Google Ventures, Kleiner Perkins, Generation Investment Management, Lightspeed Venture Partners, Shasta Ventures and Venrock.www.nest.com Didi Dache, a Chinese taxi-booking app, has raised $100 million in Series C funding fromCITIC Capital($60m) and existing investors likeTencent($30m), according to a Chinese media report.www.xiaojukeji.com Alexar Therapeutics Inc., a developer of liver x receptor agonists for both systemic and local use, has raised $21.5 million in Series A funding. The company was formed by NeXeption LLC, while the investment was co-led byNew Science VenturesandThird Point Ventures. Palo Alto Investors also participated.www.alexartx.com Agilis Biotherapeutics LLC, a New York-based synthetic biology-based company focused on rare genetic diseases, has raised $8 million in new VC funding. The company also announced a partnership withIntrexon Corp.(NYSE: XON), in order to develop a treatment for Friedreich's ataxia.www.agilisbio.com Floored, a New York-based provider of 3D data capture and visualization solutions … Continue reading

Comments Off on The day in deals

Stem Cell Research – Stem Cell Treatments – Treatments Using …

Posted: Published on January 3rd, 2014

COMPARE CORD BLOOD BANKS Choosing the right stem cell bank for your family is rarely a quick decision. But when you review the facts, you may find it much easier than you expected. Keep Reading > 1. The collection of cord blood can only take place at the time of delivery, and advanced arrangements must be made. Cord blood is collected from the umbilical cord immediately after a babys birth, but generally before the placenta has been delivered. The moment of delivery is the only opportunity to harvest a newborns stem cells. 2. There is no risk and no pain for the mother or the baby. The cord blood is taken from the cord once it has been clamped and cut. Collection is safe for both vaginal and cesarean deliveries. 3. The body often accepts cord blood stem cells better than those from bone marrow. Cord blood stem cells have a high rate of engraftment, are more tolerant of HLA mismatches, result in a reduced rate of graft-versus-host disease, and are rarely contaminated with latent viruses. 4. Banked cord blood is readily accessible, and there when you need it. Matched stem cells, which are necessary for transplant, are difficult to … Continue reading

Posted in Stem Cell Research | Comments Off on Stem Cell Research – Stem Cell Treatments – Treatments Using …

Study finds patients give ‘broad endorsement’ to stem cell research

Posted: Published on January 3rd, 2014

Jan. 2, 2014 In an early indication of lay opinions on research with induced pluripotent stem cells (iPSCs), which are stem cells made from skin or other tissues, a new study by bioethicists at Johns Hopkins University indicates that despite some ethical concerns, patients give the research "broad endorsement." During focus group discussions patients were largely in favor of participating in iPSC research even if personal benefit was unlikely, though they raised concerns about consent, privacy and transparency when considering donating tissue for this research. The bioethicists report their findings in the journal Cell Stem Cell. "Bioethicists, as well as stem cell researchers and policy-makers, have discussed the ethical issues of induced pluripotent stem cells at length, but we didn't have any systematic information about what patients think about these issues, and that is a huge part of the equation if the potential of this research is to be fully realized,"says Jeremy Sugarman, the senior author of the report and the Harvey M. Meyerhoff Professor of Bioethics and Medicine at the Johns Hopkins Berman Institute of Bioethics. Unlike human embryonic stem cells, iPSCs are derived without destroying a human embryo. Research with human iPSCs is valuable for developing new drugs, … Continue reading

Posted in Stem Cell Research | Comments Off on Study finds patients give ‘broad endorsement’ to stem cell research

Stem cell transplantation: new approach ‘protects from rejection’

Posted: Published on January 3rd, 2014

Current ratings for: Stem cell transplantation: new approach 'protects from rejection' Public / Patient: 0 (0 votes) Health Professionals: 0 (0 votes) Many patients who undergo stem cell transplantations run the risk that their immune system may reject the donor cells. But new research from the University of California-San Diego has detailed a new approach that may help tackle this problem. This is according to a study published in the journal Cell Stem Cell. The research team, led by Yang Xu, says their findings may also provide researchers with a better understanding as to how tumors avert the immune system as they spread throughout the human body. In collaboration with researchers from China, the investigators created "humanized" laboratory mice. The mice had a functional human immune system that was able to effectively reject a large number of foreign cells that originated from human embryonic stem cells. The researchers explain that since human embryonic stem cells are "allogenic," meaning they differ from the body's own cells, a healthy human immune system will naturally attack the stem cells. Go here to see the original: Stem cell transplantation: new approach 'protects from rejection' … Continue reading

Posted in Stem Cell Research | Comments Off on Stem cell transplantation: new approach ‘protects from rejection’

Growing Research Focus on Single Cell Biology Drives the Market for Single Cell Omics, According to a New Trend Report …

Posted: Published on January 3rd, 2014

San Jose, CA (PRWEB) January 03, 2014 Follow us on LinkedIn Single Cell Omics, a cutting edge technology, mainly integrates advanced technology with biology for a variety of single cell applications. Single Cell Omics, a strong diagnostic and clinical research tool, enables researchers in comprehending cellular variations during cell proliferation; investigating cycle-dependent effects in single cells; and detecting cellular subpopulations as well as differentiation states. Developments targeted at improving sensitivity and throughput of single cell omics technologies are additionally expected to benefit the market. The trend report titled Single Cell Omics announced by Global Industry Analysts Inc., is a focused research paper which provides cursory insights into the technology, its evolution, applications, and future prospects. In addition to providing coverage on corporate initiatives of key companies worldwide, the report also offers global market estimates and projections for Single Cell Omics technology and products in US dollars for years 2012 through 2017. Key geographic market quantitatively analysed include the Unites States, Europe, Asia Pacific, and Japan. Also covered are companies such as BD Biosciences, BioNano Genomics Inc., DVS Sciences Inc., Fluidigm Corp., and Life Technologies Corp., among others. For more details about this trend report, please visit http://www.strategyr.com/TrendReport.asp?code=146035. About Global Industry … Continue reading

Posted in Stem Cell Research | Comments Off on Growing Research Focus on Single Cell Biology Drives the Market for Single Cell Omics, According to a New Trend Report …

Stem cell therapy breakthrough

Posted: Published on January 3rd, 2014

Human embryonic stem cells have the capacity to differentiate into a variety of cell types, making them a valuable source of transplantable tissue for the treatment of numerous diseases, such as Parkinson's disease and diabetes. But theres one major issue: Embryonic stem cells are often rejected by the human immune system. Now, researchers from the University of California San Diego may have found an effective way to prevent this rejection in humans. Utilizing a novel humanized mouse model, the scientists have revealed a unique combination of immune suppressing molecules that stop the immune system from attacking the injected stem cells without shutting the system down completely. This discovery could ultimately help resolve some of the major problems currently limiting the use of embryonic stem cells for certain conditions, paving the way for the development of more effective human stem cell therapies. This is a generic way of immune suppression, so it could potentially be applied not just for stem cells therapies, but for organ transplants as well, Yang Xu, a professor of biology at UC San Diego and lead author of the study, told FoxNews.com. It can be very broad. Embryonic stem cells are different from the other cells in … Continue reading

Comments Off on Stem cell therapy breakthrough

Stem cell transplant problem solved, UCSD-led study says

Posted: Published on January 3rd, 2014

(This is my blog post about the embryonic stem cell study. For my news article about the study, go here.) Genetically modified human embryonic stem cells can solve one of the toughest problems facing embryonic stem cell therapy, immune rejection of transplanted cells, may have been solved, according to a UC San Diego-led research team. The cells can be made invisible to the immune system by genetically modifying them to make two immune-suppressing chemicals, according to a study performed in mice given a human immune system. Immune functioning in the rest of the animal remains active. The immune protection also applies to differentiated cells derived from the stem cells. If the approach works in people, patients receiving transplanted tissue or organs made from embryonic stem cells wouldn't have to take harsh immune-suppressing drugs, said Yang Xu, a UCSD professor of biology. The method also may prevent immune rejection of tissues grown from other types of stem cells. These arehumanized laboratory mice that contain a functional human immune system. Such mice have been used for years; a UCSD research team developed a model with a stronger immune response to test their immune-suppressing tissues. / Zhili Rong, UCSD Researchers placed genes in … Continue reading

Comments Off on Stem cell transplant problem solved, UCSD-led study says

Embryonic stem cell rejection problem fixed, study says

Posted: Published on January 3rd, 2014

One of the toughest problems facing embryonic stem cell therapy, immune rejection of transplanted cells, may have been solved, according to a UC San Diego-led research team. The cells can be made invisible to the immune system by genetically engineering them to make two immune-suppressing molecules, according to the study. Researchers tested the approach in mice given a human immune system. Immune functioning in the rest of the animal remained active. If the approach works in people, patients receiving transplanted tissue or organs made from embryonic stem cells wouldnt have to take harsh immune-suppressing drugs, said study leader Yang Xu, a UC San Diego professor of biology. Human embryonic stem cells. The green markers indicate the presence of a protein expressed only in these cells. / Samantha Zeitlin, 2006 CIRM fellow Researchers placed genes in the stem cells to produce the two molecules, called CTLA4-lg and PD-L1, naturally made in the body. The mice accepted transplants of heart and skin cells derived from the engineered stem cells. They rejected transplants derived from regular embryonic stem cells. The study was published online Thursday in the journal Cell Stem Cell. Its findings will have to be confirmed for safety and effectiveness before … Continue reading

Comments Off on Embryonic stem cell rejection problem fixed, study says

FEMA Search and Rescue Canine Receives Stem Cell Therapy So He Can Continue to Save Lives

Posted: Published on January 3rd, 2014

Poway, CA (PRWEB) January 02, 2014 Phizer is a seven year old black lab belonging to Ohio Task Force 1 that recently had stem cell therapy by Vet-Stem, Inc. Phizer was brought to Cleveland Road Animal Hospital for a limp in his right hind. Dr. Chad Bailey recommended stem cell therapy. Both Vet-Stem and Cleveland Road Animal Hospital value the working dog and offered their services pro-bono in hopes that Phizers stem cell therapy would permit him to continue to provide search and rescue service. Phizer is one of only five search and rescue canines owned by Ohio Task Force 1, one of 28 Task Forces across the US that make up the FEMA Urban Search and Rescue System. Phizer is trained to find living victims who may be trapped under collapsed buildings. He is unique because he is certified to work with more than one handler meaning that he can be used on more missions. If one of his handlers is not available the other may be. Phizer is trained to cover obstacles and treacherous terrain, climb metal ladders and investigate acres of terrain quickly and efficiently. These skills came in handy when Phizer was assigned to a mission … Continue reading

Comments Off on FEMA Search and Rescue Canine Receives Stem Cell Therapy So He Can Continue to Save Lives

Fem pH: Indications, Side Effects, Warnings – Drugs.com

Posted: Published on January 3rd, 2014

Generic Name: acetic acid/oxyquinoline (ah-SEE-tick ASS-id/OX-ih-KWIN-oh-lin) Brand Name: Examples include Fem pH and Relagard Increasing and maintaining vaginal acidity in combination with other medicines. It may also be used for other conditions as determined by your doctor. Fem pH is a non-irritating vaginal gel. It works by increasing the acidic level in the vagina. Contact your doctor or health care provider right away if any of these apply to you. Slideshow: 2013 Drug News Round-Up: Top 20 Stories Some medical conditions may interact with Fem pH. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you: Some MEDICINES MAY INTERACT with Fem pH. However, no specific interactions with Fem pH are known at this time. This may not be a complete list of all interactions that may occur. Ask your health care provider if Fem pH may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine. Use Fem pH as directed by your doctor. Check the label on the medicine for exact dosing instructions. Ask your health care provider any questions you may have about … Continue reading

Posted in Femtomedicine | Comments Off on Fem pH: Indications, Side Effects, Warnings – Drugs.com

Page 4,717«..1020..4,7164,7174,7184,719..4,7304,740..»